EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 231 filers reported holding EDITAS MEDICINE INC in Q2 2024. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $854,035 | -10.7% | 182,877 | +41.9% | 0.00% | – |
Q1 2024 | $956,079 | -19.0% | 128,852 | +10.6% | 0.00% | – |
Q4 2023 | $1,180,388 | -28.1% | 116,524 | -44.7% | 0.00% | – |
Q3 2023 | $1,642,648 | -7.7% | 210,596 | -2.6% | 0.00% | – |
Q2 2023 | $1,780,297 | +14.1% | 216,318 | +0.5% | 0.00% | – |
Q1 2023 | $1,559,737 | -52.7% | 215,136 | -42.2% | 0.00% | -100.0% |
Q4 2022 | $3,299,675 | +24.8% | 372,004 | +72.2% | 0.00% | 0.0% |
Q3 2022 | $2,645,000 | +5.3% | 216,066 | +1.8% | 0.00% | 0.0% |
Q2 2022 | $2,512,000 | -32.0% | 212,335 | +9.4% | 0.00% | 0.0% |
Q1 2022 | $3,692,000 | -8.5% | 194,096 | +27.7% | 0.00% | 0.0% |
Q4 2021 | $4,035,000 | -55.4% | 151,987 | -31.0% | 0.00% | -50.0% |
Q3 2021 | $9,055,000 | -19.4% | 220,423 | +11.2% | 0.00% | 0.0% |
Q2 2021 | $11,228,000 | +89.1% | 198,216 | +40.2% | 0.00% | +100.0% |
Q1 2021 | $5,937,000 | -44.0% | 141,366 | -6.5% | 0.00% | -66.7% |
Q4 2020 | $10,603,000 | +348.1% | 151,229 | +79.3% | 0.00% | +200.0% |
Q3 2020 | $2,366,000 | +13.0% | 84,321 | +19.1% | 0.00% | 0.0% |
Q2 2020 | $2,094,000 | +85.0% | 70,789 | +24.1% | 0.00% | – |
Q1 2020 | $1,132,000 | -31.1% | 57,062 | +2.8% | 0.00% | – |
Q4 2019 | $1,643,000 | +26.8% | 55,515 | -2.6% | 0.00% | – |
Q3 2019 | $1,296,000 | -14.5% | 57,021 | -6.9% | 0.00% | – |
Q2 2019 | $1,515,000 | +5.0% | 61,241 | +3.7% | 0.00% | – |
Q1 2019 | $1,443,000 | -8.1% | 59,029 | -14.5% | 0.00% | -100.0% |
Q4 2018 | $1,570,000 | -29.2% | 69,016 | -1.0% | 0.00% | 0.0% |
Q3 2018 | $2,218,000 | -21.8% | 69,701 | -11.9% | 0.00% | 0.0% |
Q2 2018 | $2,835,000 | +51.0% | 79,133 | +39.7% | 0.00% | 0.0% |
Q1 2018 | $1,878,000 | +25.2% | 56,653 | +16.1% | 0.00% | – |
Q4 2017 | $1,500,000 | +37.7% | 48,791 | +7.5% | 0.00% | – |
Q3 2017 | $1,089,000 | +111.5% | 45,376 | +47.7% | 0.00% | – |
Q2 2017 | $515,000 | -64.5% | 30,730 | -52.7% | 0.00% | – |
Q1 2017 | $1,451,000 | +80.0% | 64,980 | +31.0% | 0.00% | – |
Q4 2016 | $806,000 | +2500.0% | 49,619 | +2073.4% | 0.00% | – |
Q3 2016 | $31,000 | -70.5% | 2,283 | -46.7% | 0.00% | – |
Q2 2016 | $105,000 | +54.4% | 4,283 | +117.0% | 0.00% | – |
Q1 2016 | $68,000 | – | 1,974 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 185,668 | $5,908,000 | 4.56% |
ARK Investment Management | 2,793,854 | $88,900,000 | 2.69% |
Elmwood Wealth Management, Inc. | 94,067 | $2,993,212,000 | 2.48% |
JS Capital Management LLC | 218,935 | $6,967,000 | 1.92% |
Casdin Capital, LLC | 460,000 | $14,637,000 | 1.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,158,841 | $36,874,000 | 1.32% |
Valiant Capital Management, L.P. | 379,800 | $12,085,000 | 1.07% |
Castle Rock Wealth Management, LLC | 16,315 | $442,000 | 0.70% |
Capital Impact Advisors, LLC | 57,406 | $1,861,000 | 0.64% |
Global Thematic Partners, LLC | 481,568 | $15,323,000 | 0.60% |